InsidersTradesSigma
Browse the full record of transactions filed by Johannes Hulthe, Director. Director active across 2 companies, notably Guard Therapeutics International AB (publ). In total, 1 reports have been published. The latest transaction was filed on 4 April 2025 (Purchase). Regulator: FIN-FSA. All data is free.
1 of 1 declaration
Johannes Hulthe is a Board Member at Guard Therapeutics International AB (publ). He participates in strategic decisions and the governance of the company. His experience is valuable in guiding Guard Therapeutics in its research and development initiatives. Guard Therapeutics focuses on developing innovative treatments.